Skip to content

CENTOGENE vs Congenica

CENTOGENE logo

CENTOGENE

Empowering precision medicine through advanced diagnosis 

475 employees · est. 2006 · Rostock, Germany

VS
Congenica logo

Congenica

Driving Precision Medicine

23 employees · est. 2014 · Cambridge, United Kingdom

CENTOGENE is the older company (2006 vs 2014); CENTOGENE is the larger of the two.

Side-by-Side Comparison

CENTOGENE Congenica
Founded
2006 older 2014
Headquarters
Rostock, Germany Cambridge, United Kingdom
Employees
475 larger 23
Industry
Biotechnology, Health Care Biotechnology, Health Care, Clean Energy
Funding Stage
IPO Acquired
Total Funding
$91.80M $79.21M
Funding Rounds
6 9
Services
Whole Genome Sequencing, Multiomic Solutions, Clinical Trial Support, Genetic Testing, Bioinformatics Solutions, Patient Identification, Customized Diagnostics Genomic Data Analysis Platform, Clinical Interpretation Services, AI-powered Variant Ranking
Target Customers
Physicians, Pharmaceutical Companies, Researchers, Medical Institutions, Patients with Rare Diseases Clinicians, Laboratory Technicians, Healthcare Providers, Genomic Researchers
Taxonomy
Genetic DiagnosticsPrecision MedicineRare DiseasesGenetic TestingBiochemical DiagnosticsGenetic Data Interpretation +9 Precision MedicineGenomic Data AnalysisDigital Health SolutionsClinical Decision SupportWhole Genome SequencingNext Generation Sequencing +7
Website
centogene.com congenica.com
CENTOGENE logo

About CENTOGENE

CENTOGENE, headquartered in Germany, is a pioneer in genetic diagnostics and precision medicine. Dedicated to converting clinical, genetic, and biochemical data into actionable medical solutions, the company champions the early diagnosis and treatment of rare diseases. Since its founding in 2006, C...

Congenica logo

About Congenica

Congenica, with its slogan, "Driving Precision Medicine", is a prominent player in the digital health sector, delivering sophisticated software solutions for genomic data analysis and interpretation. Founded in 2014 in the United Kingdom, the company has built a significant reputation as an integral...

Also comparing in this category

Comparing more than these two?

Get CENTOGENE, Congenica and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does CENTOGENE compare?

A PDF of CENTOGENE and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

CENTOGENE was founded in 2006, based in Rostock, Germany, with 475 employees. CENTOGENE, headquartered in Germany, is a pioneer in genetic diagnostics and precision medicine. Dedicated to converting clinical, genetic, and biochemical data into actionable medical solutions, the. Congenica was founded in 2014, based in Cambridge, United Kingdom, with 23 employees. Congenica, with its slogan, "Driving Precision Medicine", is a prominent player in the digital health sector, delivering sophisticated software solutions for genomic data analysis and interpretation.
CENTOGENE has raised $91.80M and Congenica $79.21M. Latest stage: CENTOGENE IPO, Congenica Acquired.
Both work in Biotechnology and Health Care and list precision medicine, next generation sequencing and whole genome sequencing among their focus areas.

Compare CENTOGENE with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at CENTOGENE on 28 May 2026, and Congenica on 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout